Webmail
HelpDesk
Personal Area
RESEARCH
DIAGNOSTICS
TRANSLATION
OUTREACH
Papers
Author:
Title:
Journal:
Year:
Papers found: 3464
Pages: 1/347
Note: This data was collect using the ISI Web of Science database.
Legend:
C - Citations
IF - Impact Factor
(*) Last Impact Factor reported
C
IF
1. Ruivo CF, Bastos N,
Adem B
,
Batista I
, Duraes C, Melo CA, Castaldo SA, Campos-Laborie F, Moutinho-Ribeiro P, Morão B, Costa-Pinto A, Silva S,
Osorio H
, Ciordia S,
Costa JL
, Goodrich D, Cavadas B,
Pereira L
, Kouzarides T, Macedo G, Maio R,
Carneiro F
, Cravo M, Kalluri R,
Machado JC
,
Melo SA
Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression.
Gut 71: , 2022.
[Article - 2043-68; Epub ahead of print]
doi:
10.1136/gutjnl-2021-324994
PMID:
35012996
.
41
31.8 (*)
2. Sousa C, Ferreira R, Azevedo NF, Oleastro M, Azeredo J,
Figueiredo C
, Melo LDR
Helicobacter pylori infection: from standard to alternative treatment strategies.
Critical reviews in microbiology 48: 376-396, 2022.
[Review]
doi:
10.1080/1040841X.2021.1975643
PMID:
34569892
.
23
-
3. Nogueira-Rodrigues J, Leite SC, Pinto-Costa R, Sousa SC, Luz LL, Sintra MA, Oliveira R, Monteiro AC, Pinheiro GG, Vitorino M, Silva JA, Simão S, Fernandes VE, Provazník J, Benes V, Cruz CD, Safronov BV,
Magalhães A
,
Reis CA
, Vieira J, Vieira CP, Tiscórnia G, Araújo IM, Sousa MM
Rewired glycosylation activity promotes scarless regeneration and functional recovery in spiny mice after complete spinal cord transection.
Developmental cell 57: 440-450.e7, 2022.
[Article]
doi:
10.1016/j.devcel.2021.12.008
PMID:
34986324
.
18
-
4. Diniz F, Coelho P,
Duarte HO
, Sarmento B,
Reis CA
,
Gomes J
Glycans as Targets for Drug Delivery in Cancer.
Cancers 14: ., 2022.
[Review]
doi:
10.3390/cancers14040911
PMID:
35205658
.
18
6.6 (*)
5. Pereira F, Ferreira A,
Reis CA
, Sousa MJ, Oliveira MJ, Preto A
KRAS as a Modulator of the Inflammatory Tumor Microenvironment: Therapeutic Implications.
Cells 11: ., 2022.
[Review]
doi:
10.3390/cells11030398
PMID:
35159208
.
14
7.7 (*)
6. Miranda F,
Prazeres H
, Mendes F, Martins D,
Schmitt F
Resistance to endocrine therapy in HR¿+¿and/or HER2¿+¿breast cancer: the most promising predictive biomarkers.
Molecular biology reports 49: 717-733, 2022.
[Review]
doi:
10.1007/s11033-021-06863-3
PMID:
34739691
.
14
-
7. Conceição F, Sousa DM, Loessberg-Zahl J, Vollertsen AR, Neto E, Søe K,
Paredes J
, Leferink A, Lamghari M
A metastasis-on-a-chip approach to explore the sympathetic modulation of breast cancer bone metastasis.
Materials today. Bio 13: 100219, 2022.
[Article]
doi:
10.1016/j.mtbio.2022.100219
PMID:
35243294
.
14
-
8.
Abrantes R
,
Duarte HO
,
Gomes C
, Wälchli S,
Reis CA
CAR-Ts: new perspectives in cancer therapy.
FEBS letters 596: 403-416, 2022.
[Review]
doi:
10.1002/1873-3468.14270
PMID:
34978080
.
13
-
9. Morais M, Pinto DM,
Machado JC
, Carneiro S
ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 48: 218-227, 2022.
[Review]
doi:
10.1016/j.ejso.2021.08.034
PMID:
34511270
.
8
4.4 (*)
10. Chandra A,
Schmitt F
Cytologic diagnosis of "atypical" in serous fluid cytopathology. Approach of the international system for reporting serous fluid cytopathology.
Diagnostic cytopathology 50: 208-211, 2022.
[Review]
doi:
10.1002/dc.24864
PMID:
34499418
.
3
1.6 (*)
Next
Send Email
From
To
Subject